Comparative Evaluation of Direct Thrombin and Factor Xa Inhibitors with Antiplatelet Agents under Flow and Static Conditions: An In Vitro Flow Chamber Model-Reference-Cited by-同舟云学术

Comparative Evaluation of Direct Thrombin and Factor Xa Inhibitors with Antiplatelet Agents under Flow and Static Conditions: An In Vitro Flow Chamber Model

Published:2014-01-31 Issue:1 Volume:9 Page:e86491
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hosokawa Kazuya,Ohnishi Tomoko,Sameshima Hisayo,Miura Naoki,Koide Takehiko,Maruyama Ikuro,Tanaka Kenichi A.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference28 articles.

1. New anticoagulants for treatment of venous thromboembolism;PL Gross,2008

2. The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans;S Blech,2008

3. Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor;D Kubitza,2005

4. Triple therapy of warfarin, aspirin and a thienopyridine for patients treated with vitamin K antagonists undergoing coronary stenting. A review of the evidence;A Rubboli,2007

5. Combination antithrombotic therapies;PA Gurbel,2010

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric Mesangial Proliferative Glomerulonephritis Has Increased the Platelet Thrombus Formation Potentials under High-Shear Flow Condition;Nephron;2023-10-09

2. DOAC–associated bleeding, hemostatic strategies, and thrombin generation assays - a review of the literature;Journal of Thrombosis and Haemostasis;2023-03

3. Effect of Apixaban Pretreatment on Alteplase-Induced Thrombolysis: An In Vitro Study;Frontiers in Pharmacology;2021-09-15

4. The Use of Total Thrombus Formation Analysis System as a Tool to Assess Platelet Function in Bleeding and Thrombosis Risk—A Systematic Review;International Journal of Molecular Sciences;2021-08-10

5. Microfluidics in cardiovascular disease research: state of the art and future outlook;Microsystems & Nanoengineering;2021-03-03